The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy.

Cancer Med · 2023 · PMC10166924 · PMID 36825549

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

2 , 3 , 4 , 5 , 6 , 7 Accumulating evidence from previous studies showed a trend of better survival outcomes in ICI patients who were concomitantly treated with certain medications, such as renin‐angiotensin‐aldosterone system inhibitors (RAASi). 3 , 7 , 8 , 9 , 10 , 11 Experimental studies have shown that the renin‐angiotensin‐aldosterone system (RAAS)

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.